Driving the future of data-driven biomedicine
Join Nexyra in its mission to transform omics sciences into accessible and scalable solutions for precision medicine. We are opening a new frontier in biomedical analysis with artificial intelligence, multi-omics integration, and quantum computing.
We’re building innovative tech solutions oriented around clinical care and research products—and the virtuous cycle between them.
Our Market Opportunity
Global Omics Market: $45B+, with a projected CAGR of 12-15% through 2030.
+80% of clinical omics data is not utilized or integrated today.
Nexyra covers everything from transcriptomics and metabolomics to emerging layers such as epigenomics and proteomics, with deliveries in <72 hours.
Breaking the limits
At Nexyra, we turn complexity into clarity.
We create competitive advantage by uncovering what others can't see: latent patterns hidden in multimodal biological data, unexpected relationships between genes, drugs, and diseases that unlock new clinical and scientific pathways.
Our platform provides deep, structured insight into complex biomolecular interactions, powered by AI algorithms capable of connecting, interpreting, and surfacing previously invisible connections—where innovation meets biological intelligence.
This is not just data analysis.
It’s actionable insight at the molecular level, designed to accelerate discovery, precision diagnosis, and therapeutic innovation.
Company Highlights
Improving patient care through high-quality omics data analysis, clinical trial compatibility, and comprehensive research data that drive scientific discovery.
Powered by UCAM HiTech: Nexyra accelerates its growth with Lean Launchpad methodology
Nexyra has participated in the UCAM HiTech acceleration program, a leading center for innovation and health, which promotes business digital transformation through proven methodologies such as Lean Launchpad.
Selected as one of the three most innovative startups at the Madrid Science Park through the APTenisa program
Nexyra has been chosen among the main initiatives promoted by the Madrid Science Park within the national APTenisa program, which in its 2025 edition promotes the innovation of 72 highly technological startups.
Guests at the Transfiere 2026 Forum, the main European R&D&I forum in Spain
Nexyra has been invited to participate in the fifteenth edition of Transfiere (March 18-20, 2026), the leading European forum on knowledge transfer, science and technology in Malaga.